Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Medicare drug plan costs are surging. A KFF analysis finds average standalone Part D premiums will rise 50% — from $34 to $51/month in 2027 — if seniors don't switch plans. With open enrollment running until Dec. 7, experts are urging beneficiaries to shop around, as premiums vary widely from $6.50 to $204.50 per month across national carriers.
Medicare's prescription drug coverage is getting a lot more expensive. A new KFF analysis finds that average monthly premiums for standalone Part D plans will jump 50% — from $34 to $51 — in 2027, assuming seniors stay on their current plans. The Trump administration's early termination of a premium stabilization program is seen as a contributing factor to the spike.
The stakes are especially high this year because there are no zero-premium Part D plans available in 2027, meaning the 4+ million seniors currently enrolled in such plans will face new costs unless they act. Premiums across national carriers range dramatically — from $6.50/month (Centene's Wellcare Value Script Rx) to $204.50/month (United's AARP Medicare Rx Preferred) — making plan comparison essential.
By the Numbers:
Why it matters: With open enrollment open through Dec. 7, seniors who don't actively shop for a new plan could face significantly higher drug costs in 2027. Healthcare providers should be ready to guide patients — especially those on fixed incomes — through their coverage options.
